CAS: 115314-14-2; (S)-Oxiran-2-Ylmethyl 3-Nitrobenzenesulfonate

上下游产品

CAS号121-51-7 3-硝基苯磺酰氯 | CAS号60456-23-7 (S)-缩水甘油 | CAS号57044-25-4 (|R|)-(+)-缩水甘油 | CAS号60827-45-4 |S|-(+)-3-氯-1,2-丙二醇 | CAS号95093-95-1 甘氨熊胆酸 | CAS号198226-53-8 (R)-2-chloro-6-... | CAS号93379-54-5 (S)-(-)-阿替洛尔 | CAS号159873-06-0 1-(2,3-环氧基丙基)-4... | CAS号71031-03-3 (S)-环氧丙基苯基醚 | CAS号5255-75-4 1,2-环氧-3-(4-硝基苯氧基)丙烷 | CAS号14618-80-5 (-)-苯甲基-(R)-环氧丙基醚 | CAS号4199-10-4 (S)-(-)-普奈洛尔 盐酸盐 | CAS号105780-38-9 吡氟甲禾灵 | CAS号171721-34-9 (S)-2-((3-硝基苯氧基...

4-氨基-2,3,5-三甲基苯酚 以96的收率获得(S)-(+)-间硝基苯磺酸缩水甘油酯
参考文献:J. Med. Chem. 2000,43,3372-3376
标题:J. Med. Chem. 2000,43,3372-3376

专利信息

专利号:US-6087512-A
优先权日:1996-09-18
标题:Process for preparation of glycidyl ether
发明人：FURUKAWA YOSHIRO; KITAORI KAZUHIRO; YANAGIMOTO TETSUYA; MIKAMI MASAFUMI; YOSHIMOTO HIROSHI; OTERA JUNZO
权利人:DAISO CO LTD
摘要:A process for preparation of a glycidyl ether which is characrelized in reacting an epoxy compound of the formula ##STR1## wherein X is halogen or sulfonyloxy in the presence of a fluoride salt, with an alcohol. According to the above method, glycigyl ethers or their optically active compounds important as intermediates for synthesis of medicines are easily obtained in good yield and especially the optically active compounds are obtained with highly optical purity.

专利号:US-6057476-A
优先权日:1996-09-18
标题:Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
发明人：FURUKAWA YOSHIRO; KITAORI KAZUHIRO; MIKAMI MASAFUMI; YOSHIMOTO HIROSHI; OTERA JUNZO
权利人:DAISO CO LTD
摘要:A process for preparation of 3-amino-2-hydroxy-1-propyl ether of the formula ##STR1## wherein R 1 is substituted or unsubstituted alkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heterocyclic ring, R 2 and R 3 are the same or different hydrogen atom, a substituted or unsubstituted alkyl, or may form a ring together with an adjacent nitrogen atom, which ring may be interrupted with nitrogen atom, oxygen atom or sulfur atom, n which is characterized in reacting an epoxy compound of the formula ##STR2## wherein X is halogen, in the presence of a fluoride salt, with an alcohol and then reacting an amine. n According to the above method, an intermediates for synthesis of medicines is obtained in good yield and highly optical purity.

专利号:US-2009247618-A1
优先权日:2008-03-26
标题 :Process for preparation of benzo-fused heteroaryl derivatives
发明人：BALLENTINE SCOTT A; REANY LAURA
权利人:BALLENTINE SCOTT A; REANY LAURA
摘要:The present invention is directed to processes for the preparation of benzo-fused heteroaryl derivatives, useful for the treatment of epilepsy and related disorders. The present invention is further directed to processes for the preparation of intermediates in the synthesis of the benzo-fused heteroaryl derivatives.

专利号:US-7053236-B2
优先权日:2000-04-04
标 题 :Catalytic asymmetric desymmetrization of prochiral and meso compounds
发明人：DENG LI; CHEN YONGGANG; TIAN SHIKAI
权利人:UNIV BRANDEIS
摘要:The present invention relates to methods for the synthesis of chiral non-racemic products, e.g., enantiomerically-enriched hemiesters, from prochiral and meso starting materials, e.g., prochiral and meso cyclic anhydrides. The present invention also relates to catalysts for the aforementioned methods, and methods for synthesizing these catalysts.

专利号:US-7060840-B2
优先权日:2000-04-04
标 题 :Catalytic asymmetric desymmetrization of prochiral compounds
发明人：DENG LI; CHEN YONGGANG; TIAN SHIKAI
权利人:UNIV BRANDEIS
摘要:The present invention relates to methods for the synthesis of chiral non-racemic products, e.g., enantiomerically-enriched hemiesters, from prochiral starting materials, e.g., meso anhydrides. The present invention also relates to catalysts for the aforementioned methods, and methods for synthesizing these catalysts.

专利号:US-2024383853-A1
优先权日:2021-09-28
标题:Oximes and their use in treatment of gba-related diseases
发明人：NEVE SØREN; BROWN WILLIAM DALBY; THIRSTRUP KENNETH
权利人:ZEVRA DENMARK AS
摘要:The present invention relates to oximes, their synthesis, and their use for increasing GBA activity and/or levels as well as treatment of GBA-related diseases, such as Parkinson's disease.